Canada Considers Performance-Based Outcome Reimbursement Deals For Oncology Drugs
Executive Summary
Manufacturers selling oncology drugs in Canada could soon face group price negotiations and performance-based reimbursement agreements as authorities in the country plan to improve access to oncology drugs.